Literature is scanty on the interaction potential of Hibiscus sabdariffa L., plant extract with other drugs and the affected targets. This study was conducted to investigate the cytochrome P450 (CYP) isoforms that are inhibited by the extract of Hibiscus sabdariffa L. in vitro. The inhibition towards the major drug metabolizing CYP isoforms by the plant extract were estimated in human liver microsomal incubations, by monitoring the CYP-specific model reactions through previously validated N-in-one assay method. The ethanolic extract of Hibiscus sabdariffa showed inhibitory activities against nine selected CYP isoforms: CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4. The concentrations of the extract which produced 50% inhibition of the CYP isoforms ranged from 306 µg/ml to 1660 µg/ml, and the degree of inhibition based on the IC 50 values for each CYP isoform was in the following order: CYP1A2 > CYP2C8 > CYP2D6 > CYP2B6 > CYP2E1 > CYP2C19 > CYP3A4 >> CYP2C9 >> CYP2A6. Ethanolic extract of Hibiscus sabdariffa caused inhibition of CYP isoforms in vitro. These observed inhibitions may not cause clinically significant herb-drug interactions; however, caution may need to be taken in co-administering the water extract of Hibiscus sabdariffa with other drugs until clinical studies are available to further clarify these findings.Key words: Cytochrome P450, Hibiscus sabdariffa, Herb-drug interaction, Anthocyanin, N-in-one assay.
List of non-standard abbreviations: TMA -Total Monomeric Anthocyanin, EEHS -ethanolic extract of Hibiscus sabdariffa, EAR -Enzyme activity remaining.
IntroductionHerbal remedies have been in use over the ages until synthetic drugs became available, however, there has been resurgence in the use of herbal remedies. This resurgence has led to increase in the concomitant use of herbs with conventional medicines with the belief that the potency of either the herb or the conventional medicine may be enhanced. But the concomitant use of herbs with conventional medicines has given rise to various potential interactions which may not be beneficial to the user. For example Ginkgo biloba causes spontaneous bleeding when co-administered with aspirin, ibuprofen or warfarin (Bressler, 2005). Panax ginseng induces mania when used with phenelzine and St. John's Wort reduces the plasma concentrations of midazolam, digoxin and indinavir (Hu et al., 2005).Some of these potential herb-drug interactions occur when the pharmacokinetic profile of either product is altered significantly as a result of their co-administration. However most interactions occur during metabolism especially phase 1 metabolism which is mediated by cytochrome P450 (CYP) isoforms. CYP isoforms are responsible for the metabolism of about 70% of prescription drugs (Karyekar et al., 2002). The induction or inhibition of CYP isoforms by any of the product of herb and drug combination may lead to increased side effect, toxicity or therapeutic failure. Many CYP isoforms such as CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2...